Treffer 1 - 4 von 4 für Suche 'Galatin, Peter S', Suchdauer: 0,34s Treffer weiter einschränken
  1. 1
    Distress Screening Through Patient-Reported Outcomes Measurement Information System (PROMIS) at an Academic Cancer Center and Network Site: Implementation of a Hybrid Model

    Distress Screening Through Patient-Reported Outcomes Measurement Information System (PROMIS) at an Academic Cancer Center and Network Site: Implementation of a Hybrid Model von Neal, Joel W, Roy, Mohana, Bugos, Kelly, Sharp, Christopher, Galatin, Peter S, Falconer, Patricia, Rosenthal, Eben L, Blayney, Douglas W, Modaressi, Shiva, Robinson, Ashley, Ramchandran, Kavitha

    Veröffentlicht in JCO oncology practice

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    A Nonpeptidic Sulfonamide Inhibits the p53−mdm2 Interaction and Activates p53-Dependent Transcription in mdm2-Overexpressing Cells

    A Nonpeptidic Sulfonamide Inhibits the p53−mdm2 Interaction and Activates p53-Dependent Transcription in mdm2-Overexpressing Cells von Galatin, Peter S, Abraham, Donald J

    Veröffentlicht in Journal of medicinal chemistry

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Phase I trial of oblimersen (Genasense®) and gemcitabine in refractory and advanced malignancies

    Phase I trial of oblimersen (Genasense®) and gemcitabine in refractory and advanced malignancies von Galatin, Peter S., Advani, Ranjana H., Fisher, George A., Francisco, Brian, Julian, Thomas, Losa, Raquel, Sierra, Marta I., Sikic, Branimir I.

    Veröffentlicht in Investigational new drugs

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    QSAR: Hydropathic analysis of inhibitors of the p53-mdm2 interaction

    QSAR: Hydropathic analysis of inhibitors of the p53-mdm2 interaction von Galatin, Peter S., Abraham, Donald J.


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: